Market Overview:
The global organ perfusion system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of organ failures, technological advancements in organ perfusion systems, and rising demand for donor organs. Based on type, the global organ perfusion system market is segmented into isolated heart perfusion systems, isolated lung perfusion systems, and isolated abdominal organ perfusion systems. The isolated heart perfu-sion systems segment is expected to account for the largest share of the global market in 2018. This can be attributed to factors such as growing demand for cardiac transplants and increasing number of cardiothoracic surgeries. Based on application, the global market is segmented into laboratory applications, hospital applications, pet clinic applications, medical college applications and other appli-cations segments.
Product Definition:
The organ perfusion system is a device that is used to pump blood through the organs of the body. This system is important because it helps to keep the organs healthy and functioning properly.
Isolated Heart Perfusion Systems:
IHPP is a technique that involves the delivery of blood to an isolated heart and then re-circulation of that blood through the body without allowing it to go through the liver. This results in higher bioavailability of nutrients, better nutrient distribution & utilization, increased rate & extent of tissue healing, reduced systemic inflammatory response and improved functional recovery as compared to conventional perfusion methods.
Isolated Lung Perfusion Systems:
The global Isolated Lung Perfusion Systems and it's usage in Organ Perfusion System market size was valued at USD 1.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising number of lung transplantation procedures along with increasing demand for ILP systems globally are some high impact rendering drivers for the growth of this industry during the forecast period 2015-2022.
Application Insights:
The hospital application segment dominated the global organ perfusion system market in 2017 and is expected to maintain its dominance over the forecast period. The increasing number of hospitals, increase in patient admissions, and rising geriatric population are some of the major factors driving this segment. Moreover, a rise in cardiovascular diseases is further anticipated to boost demand for OAP at hospitals during the forecast period.
Laboratory application accounted for a significant share owing to growing usage of lab-on-chip technology which has enabled rapid progress in molecular biology research coupled with high throughput screening techniques. This has led to an increased need for OAP systems that can meet up with high demands from researchers across various fields such as drug discovery & development and clinical diagnostics applications.
Regional Analysis:
North America dominated the global organ perfusion system market in 2016. This can be attributed to increasing research and development activities by major players, high adoption of advanced technologies, presence of well-developed healthcare infrastructure and favorable reimbursement policies & regulatory reforms. In addition, growing number of transplantation procedures are expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising patient awareness about organ donation coupled with government initiatives for promoting transplants in this region. For instance, Ministry of Health & Family Welfare (MoHFW) has framed several acts and rules and regulations for implementing Organ Transplant Act 2008 that provides a legal framework for establishing a national register of donors as well as deceased organ donors/recipients in India.
Growth Factors:
- Increasing incidence of organ failures and the subsequent need for organ transplants is expected to drive the demand for organ perfusion systems over the forecast period.
- Growing awareness about the benefits of using organ perfusion systems in transplant surgeries is anticipated to boost market growth.
- Technological advancements in organ perfusion systems are likely to create new opportunities for market growth over the next few years.
- The increasing number of surgical procedures performed globally is also projected to fuel demand for Organ Perfusion System market during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Organ Perfusion System Market Research Report
By Type
Isolated Heart Perfusion Systems, Isolated Lung Perfusion Systems, Isolated Abdominal Organ Perfusion Systems, Perfusion Systems for Cell Isolation
By Application
Laboratory, Hospital, Pet Clinic, Medical College, Others
By Companies
EBERS, emka TECHNOLOGIES, Radnoti, Danish Myo Technology, MDE GmbH, Warner Instruments, Harvard Apparatus, AutoMate Scientific, OrganOx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Organ Perfusion System Market Report Segments:
The global Organ Perfusion System market is segmented on the basis of:
Types
Isolated Heart Perfusion Systems, Isolated Lung Perfusion Systems, Isolated Abdominal Organ Perfusion Systems, Perfusion Systems for Cell Isolation
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Hospital, Pet Clinic, Medical College, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EBERS
- emka TECHNOLOGIES
- Radnoti
- Danish Myo Technology
- MDE GmbH
- Warner Instruments
- Harvard Apparatus
- AutoMate Scientific
- OrganOx
Highlights of The Organ Perfusion System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Isolated Heart Perfusion Systems
- Isolated Lung Perfusion Systems
- Isolated Abdominal Organ Perfusion Systems
- Perfusion Systems for Cell Isolation
- By Application:
- Laboratory
- Hospital
- Pet Clinic
- Medical College
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organ Perfusion System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An organ perfusion system is a medical device that helps to circulate blood and other fluids throughout an organ. This can help to keep the organ healthy and functioning properly.
Some of the major companies in the organ perfusion system market are EBERS, emka TECHNOLOGIES, Radnoti, Danish Myo Technology, MDE GmbH, Warner Instruments, Harvard Apparatus, AutoMate Scientific, OrganOx.
The organ perfusion system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Organ Perfusion System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Organ Perfusion System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Organ Perfusion System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Organ Perfusion System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Organ Perfusion System Market Size & Forecast, 2020-2028
4.5.1 Organ Perfusion System Market Size and Y-o-Y Growth
4.5.2 Organ Perfusion System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Isolated Heart Perfusion Systems
5.2.2 Isolated Lung Perfusion Systems
5.2.3 Isolated Abdominal Organ Perfusion Systems
5.2.4 Perfusion Systems for Cell Isolation
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 Hospital
6.2.3 Pet Clinic
6.2.4 Medical College
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Organ Perfusion System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Organ Perfusion System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Isolated Heart Perfusion Systems
9.6.2 Isolated Lung Perfusion Systems
9.6.3 Isolated Abdominal Organ Perfusion Systems
9.6.4 Perfusion Systems for Cell Isolation
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 Hospital
9.10.3 Pet Clinic
9.10.4 Medical College
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Isolated Heart Perfusion Systems
10.6.2 Isolated Lung Perfusion Systems
10.6.3 Isolated Abdominal Organ Perfusion Systems
10.6.4 Perfusion Systems for Cell Isolation
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 Hospital
10.10.3 Pet Clinic
10.10.4 Medical College
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Isolated Heart Perfusion Systems
11.6.2 Isolated Lung Perfusion Systems
11.6.3 Isolated Abdominal Organ Perfusion Systems
11.6.4 Perfusion Systems for Cell Isolation
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 Hospital
11.10.3 Pet Clinic
11.10.4 Medical College
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Isolated Heart Perfusion Systems
12.6.2 Isolated Lung Perfusion Systems
12.6.3 Isolated Abdominal Organ Perfusion Systems
12.6.4 Perfusion Systems for Cell Isolation
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 Hospital
12.10.3 Pet Clinic
12.10.4 Medical College
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Isolated Heart Perfusion Systems
13.6.2 Isolated Lung Perfusion Systems
13.6.3 Isolated Abdominal Organ Perfusion Systems
13.6.4 Perfusion Systems for Cell Isolation
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 Hospital
13.10.3 Pet Clinic
13.10.4 Medical College
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Organ Perfusion System Market: Competitive Dashboard
14.2 Global Organ Perfusion System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EBERS
14.3.2 emka TECHNOLOGIES
14.3.3 Radnoti
14.3.4 Danish Myo Technology
14.3.5 MDE GmbH
14.3.6 Warner Instruments
14.3.7 Harvard Apparatus
14.3.8 AutoMate Scientific
14.3.9 OrganOx
